Welcome to LookChem.com Sign In|Join Free
  • or
3-Bromo-5-[1,3]dioxolan-2-yl-4,5-dihydroisoxazole is a chemical compound characterized by the molecular formula C6H7BrO3N. It is a derivative of dioxolan and dihydroisoxazole, featuring a bromine atom within its structure. 3-Bromo-5-[1,3]dioxolan-2-yl-4,5-dihydroisoxazole is recognized for its unique structural attributes and potential pharmaceutical applications, which make it a subject of interest in organic synthesis and pharmaceutical research. Additionally, it exhibits antimicrobial and anti-inflammatory properties, suggesting its potential in the development of novel drugs. However, further investigation is required to fully elucidate its biological activities and explore its possible applications.

1120215-07-7

Post Buying Request

1120215-07-7 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

1120215-07-7 Usage

Uses

Used in Organic Synthesis:
3-Bromo-5-[1,3]dioxolan-2-yl-4,5-dihydroisoxazole is utilized as a key intermediate in organic synthesis for its distinctive structural features, facilitating the creation of various complex organic molecules.
Used in Pharmaceutical Research:
In pharmaceutical research, 3-Bromo-5-[1,3]dioxolan-2-yl-4,5-dihydroisoxazole is employed as a compound of interest for its potential to contribute to the development of new pharmaceuticals, given its unique chemical properties and biological activities.
Used in Antimicrobial Applications:
3-Bromo-5-[1,3]dioxolan-2-yl-4,5-dihydroisoxazole is used as an antimicrobial agent due to its inherent properties that can combat microbial infections, making it a candidate for further exploration in the field of infectious diseases.
Used in Anti-inflammatory Applications:
3-Bromo-5-[1,3]dioxolan-2-yl-4,5-dihydroisoxazole is also used as an anti-inflammatory agent, leveraging its capacity to reduce inflammation, which is valuable in the treatment of various inflammatory conditions.
Used in Drug Development:
3-Bromo-5-[1,3]dioxolan-2-yl-4,5-dihydroisoxazole holds promise in drug development, potentially leading to the creation of new therapeutic agents. Its exploration in this area is crucial for understanding its full potential and optimizing its use in medicinal chemistry.

Check Digit Verification of cas no

The CAS Registry Mumber 1120215-07-7 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,1,2,0,2,1 and 5 respectively; the second part has 2 digits, 0 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 1120215-07:
(9*1)+(8*1)+(7*2)+(6*0)+(5*2)+(4*1)+(3*5)+(2*0)+(1*7)=67
67 % 10 = 7
So 1120215-07-7 is a valid CAS Registry Number.

1120215-07-7SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 18, 2017

Revision Date: Aug 18, 2017

1.Identification

1.1 GHS Product identifier

Product name 3-bromo-5-(1,3-dioxolan-2-yl)-4,5-dihydro-1,2-oxazole

1.2 Other means of identification

Product number -
Other names 3-bromo-5-(1,3-dioxolan-2-yl)-4,5-dihydro-isoxazole

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:1120215-07-7 SDS

1120215-07-7Downstream Products

1120215-07-7Relevant academic research and scientific papers

Synthesis of 3-aminoisoxazoles via the addition-elimination of amines on 3-bromoisoxazolines

Girardin, Melina,Alsabeh, Pamela G.,Lauzon, Sophie,Dolman, Sarah J.,Ouellet, Stephane G.,Hughes, Greg

supporting information; experimental part, p. 1159 - 1162 (2009/08/07)

A novel two-step procedure for the synthesis of 3-amino-5-substituted- isoxazoles is described. In the presence of a base, readily available 3-bromoisoxazolines react with amines to afford 3-aminoisoxazolines. An oxidation protocol was developed for these heterocycles to provide 3-aminoisoxazoles in consistently high yield.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 1120215-07-7